- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 2 x K: POTASSIUM ION(Non-covalent)
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.3: 14 residues within 4Å:- Chain A: T.273, W.275, E.276, V.278, Y.279
- Chain D: T.298, R.301, L.302, V.305
- Chain H: V.59, F.62, I.63, F.66, C.67
7 PLIP interactions:5 interactions with chain A, 1 interactions with chain D, 1 interactions with chain H- Hydrophobic interactions: A:W.275, A:W.275, A:W.275, A:V.278, A:Y.279, H:F.66
- Salt bridges: D:R.301
POV.5: 13 residues within 4Å:- Chain A: T.298, R.301, L.302, V.305
- Chain B: T.273, W.275, E.276, V.278, Y.279
- Chain E: F.62, I.63, F.66, C.67
8 PLIP interactions:5 interactions with chain B, 2 interactions with chain E, 1 interactions with chain A- Hydrophobic interactions: B:W.275, B:W.275, B:W.275, B:V.278, B:Y.279, E:I.63, E:F.66
- Salt bridges: A:R.301
POV.9: 13 residues within 4Å:- Chain B: T.298, R.301, L.302
- Chain C: T.273, W.275, E.276, V.278, Y.279
- Chain F: V.59, F.62, I.63, F.66, C.67
9 PLIP interactions:3 interactions with chain C, 1 interactions with chain B, 5 interactions with chain F- Hydrophobic interactions: C:W.275, C:W.275, C:W.275, F:F.62, F:I.63, F:I.63, F:F.66, F:F.66
- Salt bridges: B:R.301
POV.10: 13 residues within 4Å:- Chain C: T.298, R.301, L.302
- Chain D: T.273, W.275, E.276, V.278, Y.279
- Chain G: V.59, F.62, I.63, F.66, C.67
10 PLIP interactions:5 interactions with chain G, 4 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: G:F.62, G:I.63, G:I.63, G:F.66, G:F.66, D:W.275, D:W.275, D:W.275, D:W.275
- Salt bridges: C:R.301
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.4: 10 residues within 4Å:- Chain A: W.22, W.203, L.255, V.256, S.259, P.262, F.266, L.299, F.303
- Chain E: F.64
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:W.22, A:W.203, A:L.255, A:F.266
CLR.6: 9 residues within 4Å:- Chain B: W.22, W.203, L.255, V.256, S.259, P.262, F.266, L.299, F.303
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:W.203, B:W.203, B:F.266
CLR.7: 9 residues within 4Å:- Chain C: W.22, W.203, L.255, V.256, S.259, P.262, F.266, L.299, F.303
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:W.203, C:W.203, C:L.255, C:F.266
CLR.8: 8 residues within 4Å:- Chain D: W.22, W.203, L.255, V.256, S.259, F.266, L.299, F.303
5 PLIP interactions:5 interactions with chain D- Hydrophobic interactions: D:W.22, D:W.203, D:W.203, D:L.255, D:F.266
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Agarwal, S. et al., Ball-and-chain inactivation of a human large conductance calcium-activated potassium channel. Nat Commun (2025)
- Release Date
- 2025-03-05
- Peptides
- Isoform 5 of Calcium-activated potassium channel subunit alpha-1: ABCD
Large-conductance Ca2+-activated K+ channel beta2 subunit,Calcium-activated potassium channel subunit beta-4: EFGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 2 x K: POTASSIUM ION(Non-covalent)
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Agarwal, S. et al., Ball-and-chain inactivation of a human large conductance calcium-activated potassium channel. Nat Commun (2025)
- Release Date
- 2025-03-05
- Peptides
- Isoform 5 of Calcium-activated potassium channel subunit alpha-1: ABCD
Large-conductance Ca2+-activated K+ channel beta2 subunit,Calcium-activated potassium channel subunit beta-4: EFGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H - Membrane
-
We predict this structure to be a membrane protein.